171 related articles for article (PubMed ID: 34237057)
21. PKA RIα/A-kinase anchoring proteins 10 signaling pathway and the prognosis of colorectal cancer.
Wang M; Li Y; Wang R; Wang Z; Chen K; Zhou B; Zhou Z; Sun X
J Gastroenterol Hepatol; 2015 Mar; 30(3):496-503. PubMed ID: 25213315
[TBL] [Abstract][Full Text] [Related]
22. Cooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer.
Sheng W; Dong M; Chen C; Wang Z; Li Y; Wang K; Li Y; Zhou J
FASEB J; 2017 Jun; 31(6):2429-2438. PubMed ID: 28223335
[TBL] [Abstract][Full Text] [Related]
23. Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway.
Wang X; Wang R; Bai S; Xiong S; Li Y; Liu M; Zhao Z; Wang Y; Zhao Y; Chen W; Billiar TR; Cheng B
J Exp Clin Cancer Res; 2019 Dec; 38(1):505. PubMed ID: 31888685
[TBL] [Abstract][Full Text] [Related]
24. NGAL expression is elevated in both colorectal adenoma-carcinoma sequence and cancer progression and enhances tumorigenesis in xenograft mouse models.
Sun Y; Yokoi K; Li H; Gao J; Hu L; Liu B; Chen K; Hamilton SR; Fan D; Sun B; Zhang W
Clin Cancer Res; 2011 Jul; 17(13):4331-40. PubMed ID: 21622717
[TBL] [Abstract][Full Text] [Related]
25. A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients.
Li P; Xiao Z; Braciak TA; Ou Q; Chen G; Oduncu FS
PLoS One; 2017; 12(3):e0172799. PubMed ID: 28253296
[TBL] [Abstract][Full Text] [Related]
26. Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial-mesenchymal transition.
He L; Zhou X; Qu C; Hu L; Tang Y; Zhang Q; Liang M; Hong J
J Cell Mol Med; 2014 Jan; 18(1):49-58. PubMed ID: 24305552
[TBL] [Abstract][Full Text] [Related]
27. Elevated OCT1 participates in colon tumorigenesis and independently predicts poor prognoses of colorectal cancer patients.
Wang YP; Song GH; Chen J; Xiao C; Li C; Zhong L; Sun X; Wang ZW; Deng GL; Yu FD; Xue YM; Tang HM; Peng ZH; Wang XL
Tumour Biol; 2016 Mar; 37(3):3247-55. PubMed ID: 26433389
[TBL] [Abstract][Full Text] [Related]
28. Up-regulated MSI2 is associated with more aggressive chronic myeloid leukemia.
Kaeda J; Ringel F; Oberender C; Mills K; Quintarelli C; Pane F; Koschmieder S; Slany R; Schwarzer R; Saglio G; Hemmati P; van Lessen A; Amini L; Gresse M; Vagge E; Burmeister T; Serra A; Carson A; Schwarz M; Westermann J; Jundt F; Dörken B; le Coutre P
Leuk Lymphoma; 2015 Jul; 56(7):2105-13. PubMed ID: 25363400
[TBL] [Abstract][Full Text] [Related]
29. MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune-related pathways.
Veronez LC; das Chagas PF; Corrêa CAP; Baroni M; da Silva KR; Nagano LF; Borges KS; Queiroz RGP; Tone LG; Scrideli CA
J Cell Biochem; 2021 Dec; 122(12):1925-1935. PubMed ID: 34581457
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of Musashi 2 (MSI2) in cancer patients: A systematic review and meta-analysis.
Jiang L; Xue S; Xu J; Fu X; Wei J; Zhang C
Front Oncol; 2022; 12():969632. PubMed ID: 36530989
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis.
Umetani N; Takeuchi H; Fujimoto A; Shinozaki M; Bilchik AJ; Hoon DS
Clin Cancer Res; 2004 Nov; 10(22):7475-83. PubMed ID: 15569977
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of Barx2 predicts poor survival in colorectal cancer.
Mi Y; Zhao S; Zhang W; Zhang D; Weng J; Huang K; Sun H; Tang H; Zhang X; Sun X; Peng Z; Wen Y
Biochem Biophys Res Commun; 2016 Sep; 478(1):67-73. PubMed ID: 27453340
[TBL] [Abstract][Full Text] [Related]
33. The mechanisms and clinical significance of PDCD4 in colorectal cancer.
Long J; Yin Y; Guo H; Li S; Sun Y; Zeng C; Zhu W
Gene; 2019 Jan; 680():59-64. PubMed ID: 30243936
[TBL] [Abstract][Full Text] [Related]
34. Long Non-Coding RNA (lncRNA) X-Inactive Specific Transcript (XIST) Plays a Critical Role in Predicting Clinical Prognosis and Progression of Colorectal Cancer.
Zhang XT; Pan SX; Wang AH; Kong QY; Jiang KT; Yu ZB
Med Sci Monit; 2019 Aug; 25():6429-6435. PubMed ID: 31452526
[TBL] [Abstract][Full Text] [Related]
35. Dysregulated Stem Cell Markers Musashi-1 and Musashi-2 are Associated with Therapy Resistance in Inflammatory Breast Cancer.
Haiduk TS; Sicking M; Brücksken KA; Espinoza-Sánchez NA; Eder KM; Kemper B; Eich HT; Götte M; Greve B; Troschel FM
Arch Med Res; 2023 Sep; 54(6):102855. PubMed ID: 37481823
[TBL] [Abstract][Full Text] [Related]
36. Aberrant expression of long noncoding RNA SNHG15 correlates with liver metastasis and poor survival in colorectal cancer.
Huang L; Lin H; Kang L; Huang P; Huang J; Cai J; Xian Z; Zhu P; Huang M; Wang L; Xian CJ; Wang J; Dong J
J Cell Physiol; 2019 May; 234(5):7032-7039. PubMed ID: 30317592
[TBL] [Abstract][Full Text] [Related]
37. Developmental expression of Musashi-1 and Musashi-2 RNA-binding proteins during spermatogenesis: analysis of the deleterious effects of dysregulated expression.
Sutherland JM; Fraser BA; Sobinoff AP; Pye VJ; Davidson TL; Siddall NA; Koopman P; Hime GR; McLaughlin EA
Biol Reprod; 2014 May; 90(5):92. PubMed ID: 24671879
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of ncRAN, a long non-coding RNA, contributes to colorectal cancer cell migration and invasion and predicts poor overall survival for colorectal cancer patients.
Qi P; Xu MD; Ni SJ; Shen XH; Wei P; Huang D; Tan C; Sheng WQ; Zhou XY; Du X
Mol Carcinog; 2015 Sep; 54(9):742-50. PubMed ID: 24519959
[TBL] [Abstract][Full Text] [Related]
39. Novel gene hBiot2 is an independent prognostic factor in colorectal cancer patients.
Shen YM; Arbman G; Sandström P; Gullstrand P; Wei YQ; Zhang H; Rosell J; Olsson B; Peng F; Yang HS; Wang CT; Sun XF
Oncol Rep; 2012 Feb; 27(2):376-82. PubMed ID: 22024937
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemia.
Thol F; Winschel C; Sonntag AK; Damm F; Wagner K; Chaturvedi A; Göhring G; Schlegelberger B; Lübbert M; Fiedler W; Kirchner H; Krauter J; Ganser A; Heuser M
Ann Hematol; 2013 Mar; 92(3):315-23. PubMed ID: 23233047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
